Arcutis Biotherapeutics, Inc.
Climate Impact & Sustainability Data (2022)
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Patient Care
- Access and Affordability
- Community Engagement
- Human Capital Management
- Drug Safety
- Sustainable Operations
- Corporate Governance
Environmental Achievements
- All packaging is fully recyclable.
- Hybrid work model to reduce environmental footprint.
- Use of motion-sensitive lights, low-flow water fixtures, LED lighting, and electric vehicle charging stations at corporate office.
Social Achievements
- Named a Fortune’s Best Place to Work in Biopharma™ and Fortune’s Best Place to Work for Millennials™ in 2022.
- 95% of employees say it is a great place to work (compared to 57% of employees at a typical U.S.-based company).
- Employee volunteer time totaled over 2,900 hours across more than 70 different organizations.
- Arcutis and its employees contributed more than $100,000 to charitable and community organizations.
- Low employee turnover rates.
Governance Achievements
- Board oversight of ESG program managed by the Nominating and Corporate Governance Committee.
- Comprehensive information security program in place.
- Annual training on Code of Conduct and Ethics for all employees.
Climate Goals & Targets
Environmental Challenges
- Quantifying greenhouse gas emissions footprint.
- Understanding supply chain sustainability practices.
Mitigation Strategies
- Initiated assessment of greenhouse gas emissions footprint.
- Worked with third-party suppliers to understand their sustainability practices.
Supply Chain Management
Responsible Procurement
- Evaluation of suppliers' commitment to sustainability.
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: SASB, UN SDGs
UN Sustainable Development Goals
- SDG 8
- SDG 10
Arcutis' commitment to professional development, diversity and inclusion, and equitable clinical trials.
Awards & Recognition
- Fortune’s Best Place to Work in Biopharma™
- Fortune’s Best Place to Work for Millennials™